Table 3.

Content and organization comparison between neonatal formularies: Organization.

Parameter	Neofax	ANMF	DPF	NNF	Pediatric and Neonatal Lexi-Drugs	BNF for Children
Differentiation between preterm and term patients?	Yes, usually under the ‘Dose’ section	Yes	Yes	Yes	Yes, usually under the ‘Dosing: Neonatal’ section	Yes
Categories used for preterm age groups (birthweight, PNA, PMA, current weight)	Yes, based on the evidence; usually under the ‘Dose’ section	Where appropriate and indicated	If available from literature: birthweight, PNA, PMA and PCA	Where appropriate and indicated	Where appropriate and indicated; under the ‘Dosing: Neonatal’ section	Where appropriate. Usually based on weight. Corrected gestational age
Dosing recommendations are differentiated by routes of administration?	Yes	Yes	Yes	Yes	Yes, every dosing recommendation is associated with route(s) of administration	Yes
Transparency on how information is compiled	Yes	Yes	Yes	Yes	Yes	Yes
Information can be verified by references/source documentation	Yes	Yes	Yes	Yes	Yes	Yes
Extrapolation from older pediatric age groups or adults based on available data	No (would accept published literature with extrapolated data)	Yes	Yes	N/A	Evidence for dosing provided with inline citations	Yes

PMA = post-menstrual age, PNA = post-natal age, PCA = post-conceptional age, N/A = Not available.